A human monoclonal antibody targeting the conserved staphylococcal antigen IsaA protects mice against Staphylococcus aureus bacteremia.
暂无分享,去创建一个
Girbe Buist | H. Bonarius | J. V. van Dijl | S. van den Berg | I. Bakker-Woudenberg | T. Bosma | G. Buist | Jan Maarten van Dijl | Magdalena M. van der Kooi-Pol | H. Groen | K. V. van Kessel | Kok P M van Kessel | Irma A J M Bakker-Woudenberg | Tjibbe Bosma | Sanne van den Berg | Hendrik P J Bonarius | Goffe S Elsinga | Neeltje Kooi | Hans Westra | Magdalena M van der Kooi-Pol | Danny G A M Koedijk | Herman Groen | H. Westra | D. Koedijk | N. Kooi
[1] S. Foster,et al. Characterization of IsaA and SceD, Two Putative Lytic Transglycosylases of Staphylococcus aureus , 2007, Journal of bacteriology.
[2] V. Fowler,et al. Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus aureus Bacteremia , 2006, Antimicrobial Agents and Chemotherapy.
[3] S. Foster,et al. Anti-Staphylococcus aureus immunotherapy: current status and prospects. , 2009, Current opinion in pharmacology.
[4] D. Missiakas,et al. Role of Protein A in the Evasion of Host Adaptive Immune Responses by Staphylococcus aureus , 2013, mBio.
[5] J. D. Capra,et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen , 2009, Nature Protocols.
[6] A. van Belkum,et al. Characterization of the Humoral Immune Response during Staphylococcus aureus Bacteremia and Global Gene Expression by Staphylococcus aureus in Human Blood , 2013, PloS one.
[7] S. Foster,et al. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. , 2006, The Journal of infectious diseases.
[8] R. Schelonka,et al. A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin , 2006, Journal of Perinatology.
[9] H. Harmsen,et al. Mapping the Pathways to StaphylococcalPathogenesis by Comparative Secretomics , 2006, Microbiology and Molecular Biology Reviews.
[10] Michel C Nussenzweig,et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. , 2008, Journal of immunological methods.
[11] H. Bonarius,et al. High anti-staphylococcal antibody titers in patients with epidermolysis bullosa relate to long-term colonization with alternating types of Staphylococcus aureus. , 2013, The Journal of investigative dermatology.
[12] S. Cosgrove. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] D. Goldmann,et al. N Surface Polysaccharide Poly- Antibodies Specific for the Bacterial of Fully Human Monoclonal Aureus Staphylococcus Protective Activity against Characterization of the Opsonic And , 2005 .
[14] Jan Maarten van Dijl,et al. Synthetic Effects of secG and secY2 Mutations on Exoproteome Biogenesis in Staphylococcus aureus , 2010, Journal of bacteriology.
[15] R. Schelonka,et al. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. , 2007, The Journal of pediatrics.
[16] S. Cosgrove,et al. The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges , 2005, Infection Control & Hospital Epidemiology.
[17] Henry F. Chambers,et al. Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.
[18] Partially overlapping substrate specificities of staphylococcal group A sortases , 2012, Proteomics.
[19] A. Radbruch,et al. Corrigendum: Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming , 2016, Nature Medicine.
[20] L. Cope,et al. Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) , 2012, Front. Cell. Inf. Microbio..
[21] J. Köhl,et al. Staphylococcus aureus Formyl Peptide Receptor–like 1 Inhibitor (FLIPr) and Its Homologue FLIPr-like Are Potent FcγR Antagonists That Inhibit IgG-Mediated Effector Functions , 2013, The Journal of Immunology.
[22] R. Kontermann,et al. Characterization of the biological anti-staphylococcal functionality of hUK-66 IgG1, a humanized monoclonal antibody as substantial component for an immunotherapeutic approach , 2014, Human vaccines & immunotherapeutics.
[23] S. McAllister,et al. Pulsed-Field Gel Electrophoresis Typing of Oxacillin-Resistant Staphylococcus aureus Isolates from the United States: Establishing a National Database , 2003, Journal of Clinical Microbiology.
[24] C. Woods,et al. Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial of a Polyclonal Anti-Staphylococcus aureus Capsular Polysaccharide Immune Globulin in Treatment of Staphylococcus aureus Bacteremia , 2007, Antimicrobial Agents and Chemotherapy.
[25] Patrick C. Wilson,et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.
[26] S. Engelmann,et al. Proteomics uncovers extreme heterogeneity in the Staphylococcus aureus exoproteome due to genomic plasticity and variant gene regulation , 2010, Proteomics.
[27] A. Troelstra,et al. Dual effects of soluble CD14 on LPS priming of neutrophils , 1997, Journal of leukocyte biology.
[28] F. Lowy. Staphylococcus aureus infections. , 2009, The New England journal of medicine.
[29] A. van Belkum,et al. Immunotherapeutic approaches against Staphylococcus aureus. , 2011, Immunotherapy.
[30] K. Ohlsen,et al. Immunotherapeutic strategies to combat staphylococcal infections. , 2010, International journal of medical microbiology : IJMM.
[31] M. Hecker,et al. Profiling the surfacome of Staphylococcus aureus , 2010, Proteomics.
[32] S. Terakubo,et al. Subcellular Location of the Soluble Lytic Transglycosylase Homologue in Staphylococcus aureus , 2004, Current Microbiology.
[33] Sarah Dubrac,et al. Identification of Genes Controlled by the Essential YycG/YycF Two-Component System of Staphylococcus aureus , 2004, Journal of bacteriology.
[34] J. Wehland,et al. Functional Antibodies Targeting IsaA of Staphylococcus aureus Augment Host Immune Response and Open New Perspectives for Antibacterial Therapy , 2010, Antimicrobial Agents and Chemotherapy.
[35] D. Galloway,et al. Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect against Bacillus anthracis Infection and Enhance Endogenous Immunity to Anthrax , 2007, Infection and Immunity.
[36] M. Hecker,et al. Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus. , 2000, FEMS immunology and medical microbiology.
[37] L. Boon,et al. Distinctive Cytokines as Biomarkers Predicting Fatal Outcome of Severe Staphylococcus aureus Bacteremia in Mice , 2013, PloS one.